| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.38(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,142,895 |
| 52
Week Range: |
$4.32 - $9.78 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : 32.2 |
| Insider 6 Months : 33.4 |
| Insider 3/6 Months : 66 |
|
| Guru Rank Number : 661 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
37,964,167 |
44,316,834 |
44,316,834 |
44,316,834 |
| Total Buy Value |
$333,757,793 |
$369,628,561 |
$369,628,561 |
$369,628,561 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
4 |
8 |
8 |
8 |
| Total Shares Sold |
29,282 |
29,282 |
29,722 |
49,668 |
| Total Sell Value |
$219,621 |
$219,621 |
$223,295 |
$370,141 |
| Total People Sold |
2 |
2 |
2 |
2 |
| Total Sell Transactions |
2 |
2 |
3 |
7 |
| End Date |
2025-08-07 |
2025-05-06 |
2024-11-05 |
2023-11-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Leung Sandra |
Director |
• • – |
2025-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,673 |
33,822 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2025-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,065 |
265,452 |
|
- |
|
| Paulson John |
Director |
• • – |
2025-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
9,689 |
351,128 |
|
- |
|
| Carson Seana |
EVP, General Counsel |
• • – |
2025-09-08 |
4 |
AS |
$7.31 |
$97,735 |
D/D |
(13,370) |
499,585 |
|
-4% |
|
| Carson Seana |
EVP, General Counsel |
• • – |
2025-09-05 |
4 |
D |
$7.35 |
$377,327 |
D/D |
(51,337) |
512,955 |
|
- |
|
| Lee Frank D. |
Director |
• • – |
2025-08-21 |
4 |
S |
$7.66 |
$121,886 |
D/D |
(15,912) |
73,795 |
|
10% |
|
| Paulson & Co Inc |
|
– – • |
2025-08-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
70,755,869 |
|
-10% |
|
| Paulson John |
|
• • – |
2025-08-14 |
4 |
B |
$9.00 |
$312,490,062 |
I/I |
34,721,118 |
70,755,869 |
0.01 |
-10% |
|
| Paulson John |
|
• • – |
2025-08-13 |
4 |
B |
$7.06 |
$610,048 |
I/I |
86,409 |
36,034,751 |
0.01 |
-5% |
|
| Paulson John |
|
• • – |
2025-08-12 |
4 |
B |
$6.88 |
$7,957,683 |
I/I |
1,156,640 |
35,948,342 |
0.01 |
-3% |
|
| Paulson John |
|
• • – |
2025-08-11 |
4 |
B |
$6.35 |
$12,700,000 |
I/I |
2,000,000 |
34,791,702 |
0.01 |
2% |
|
| Goettler Michael |
Director |
• • – |
2025-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
30,149 |
30,149 |
|
- |
|
| Leung Sandra |
Director |
• • – |
2025-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
30,149 |
30,149 |
|
- |
|
| Lenar Aimee J. |
EVP, US Pharma |
• • – |
2025-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
30,847 |
260,774 |
|
- |
|
| Lenar Aimee J. |
EVP, US Pharma |
• • – |
2025-07-15 |
4 |
D |
$6.42 |
$145,965 |
D/D |
(22,736) |
229,927 |
|
- |
|
| Lee Steven Hyosig |
SVP, Controller & CAO |
• • – |
2025-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
27,371 |
27,371 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2025-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,032 |
264,387 |
|
- |
|
| Paulson John |
Director |
• • – |
2025-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
9,384 |
341,439 |
|
- |
|
| Icahn Brett |
Director |
• • – |
2025-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,034 |
220,280 |
|
- |
|
| Paulson John |
|
• • – |
2025-06-13 |
4 |
B |
$5.94 |
$21,170,510 |
I/I |
3,564,059 |
32,791,702 |
0.01 |
4% |
|
| Paulson John |
|
• • – |
2025-06-12 |
4 |
B |
$5.47 |
$5,499,407 |
I/I |
1,005,376 |
29,227,643 |
0.01 |
12% |
|
| Paulson John |
|
• • – |
2025-06-11 |
4 |
B |
$5.24 |
$5,392,474 |
I/I |
1,029,098 |
28,222,267 |
0.01 |
18% |
|
| Paulson John |
|
• • – |
2025-06-10 |
4 |
B |
$5.05 |
$3,808,377 |
I/I |
754,134 |
27,193,169 |
0.01 |
19% |
|
| Power Robert N |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
254,723 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
263,355 |
|
- |
|
645 Records found
|
|
Page 1 of 26 |
|
|
0.09 (1.33%) 
